Published in 2021 this randomized, double-blind, placebo-controlled study was conducted on 46 NAFLD patients. Researchers concluded that supplementation over 12 weeks has a positive impact on patients with NAFLD’s leptin, adiponectin, oxidative stress (expect glutathione peroxidase), and body weight, compared to baseline.
References:
Kooshki F, Moradi F, Karimi A, Niazkar HR, Khoshbaten M, Maleki V, Pourghassem Gargari B. Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. Eur J Gastroenterol Hepatol. 2021 Oct 1;33(10):1298-1306. doi: 10.1097/MEG.0000000000001830. PMID: 32804855.
